These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 27547944)

  • 1. Disease-specific Pay-for-Performance Programs: Do the P4P Effects Differ Between Diabetic Patients With and Without Multiple Chronic Conditions?
    Huang YC; Lee MC; Chou YJ; Huang N
    Med Care; 2016 Nov; 54(11):977-983. PubMed ID: 27547944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association between participation in a pay-for-performance program and macrovascular complications in patients with type 2 diabetes in Taiwan: A nationwide population-based cohort study.
    Hsieh HM; Lin TH; Lee IC; Huang CJ; Shin SJ; Chiu HC
    Prev Med; 2016 Apr; 85():53-59. PubMed ID: 26740347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does the pay-for-performance programme reduce the emergency department visits for hypoglycaemia in type 2 diabetic patients?
    Yu HC; Tsai WC; Kung PT
    Health Policy Plan; 2014 Sep; 29(6):732-41. PubMed ID: 23894069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does pay-for-performance benefit patients with multiple chronic conditions? Evidence from a universal coverage health care system.
    Chen CC; Cheng SH
    Health Policy Plan; 2016 Feb; 31(1):83-90. PubMed ID: 25944704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of diabetes pay-for-performance incentive designs.
    Hsieh HM; Tsai SL; Shin SJ; Mau LW; Chiu HC
    Med Care; 2015 Feb; 53(2):106-15. PubMed ID: 25397966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors related to continuing care and interruption of P4P program participation in patients with diabetes.
    Yen SM; Kung PT; Sheen YJ; Chiu LT; Xu XC; Tsai WC
    Am J Manag Care; 2016 Jan; 22(1):e18-30. PubMed ID: 26799201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of pay for performance on risk incidence of hip fracture in type 2 diabetic patients: a nationwide population-based cohort study.
    Lee YH; Kung PT; Kuo WY; Kao SL; Tsai WC
    Medicine (Baltimore); 2020 Mar; 99(12):e19592. PubMed ID: 32195973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient assessment of diabetes care in a pay-for-performance program.
    Chiu HC; Hsieh HM; Lin YC; Kuo SJ; Kao HY; Yeh SC; Chang WH; Hsiao PJ; Chen YS; Lin SL; Lo GH; Ker CG; Hung YH; Cheng HA; Chou TH; Chou SY; Wang JH; Wang CF
    Int J Qual Health Care; 2016 Apr; 28(2):183-90. PubMed ID: 26819445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the relationship between a chronic disease care management program and california pay-for-performance diabetes care cholesterol measures in one medical group.
    Cutler TW; Palmieri J; Khalsa M; Stebbins M
    J Manag Care Pharm; 2007 Sep; 13(7):578-88. PubMed ID: 17874864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effectiveness of a pay for performance program on diabetes care in Taiwan: A nationwide population-based longitudinal study.
    Lin TY; Chen CY; Huang YT; Ting MK; Huang JC; Hsu KH
    Health Policy; 2016 Nov; 120(11):1313-1321. PubMed ID: 27780591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Changes in Diabetes Pay-for-Performance Incentive Designs on Patient Risk Selection.
    Hsieh HM; Tsai SL; Mau LW; Chiu HC
    Health Serv Res; 2016 Apr; 51(2):667-86. PubMed ID: 26152649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pay-for-performance programmes reduce stroke risks in patients with type 2 diabetes: a national cohort study.
    Chou CW; Kung PT; Chou WY; Tsai WC
    BMJ Open; 2019 Oct; 9(10):e026626. PubMed ID: 31619415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of individual and neighborhood social risks on diabetes pay-for-performance program under a single-payer health system.
    Tsai WC; Huang KH; Chen PC; Chang YC; Chen MS; Lee CB
    Soc Sci Med; 2023 Jun; 326():115930. PubMed ID: 37146356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects and Factors Related to Adherence to A Diabetes Pay-for-Performance Program: Analyses of a National Health Insurance Claims Database.
    Chi MJ; Chou KR; Pei D; Hwang JS; Quinn L; Chung MH; Liao YM
    J Am Med Dir Assoc; 2016 Jul; 17(7):613-9. PubMed ID: 27073041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Pay-for-Performance for Primary Care Physicians on Preventable Diabetes-Related Hospitalization Costs Among Adults in New Brunswick, Canada: A Quasiexperimental Evaluation.
    Gupta N; Lavallée R; Ayles J
    Can J Diabetes; 2019 Jul; 43(5):354-360.e1. PubMed ID: 30679059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of pay-for-performance program on infection events and mortality rate in diabetic patients: a nationwide population-based cohort study.
    Wu YF; Chen MY; Chen TH; Wang PC; Peng YS; Lin MS
    BMC Health Serv Res; 2021 Jan; 21(1):78. PubMed ID: 33478477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing Taiwan's pay-for-performance program for diabetes care: a cost-benefit net value approach.
    Lu JR; Chen YI; Eggleston K; Chen CH; Chen B
    Eur J Health Econ; 2023 Jul; 24(5):717-733. PubMed ID: 35995886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The unintended consequence of diabetes mellitus pay-for-performance (P4P) program in Taiwan: are patients with more comorbidities or more severe conditions likely to be excluded from the P4P program?
    Chen TT; Chung KP; Lin IC; Lai MS
    Health Serv Res; 2011 Feb; 46(1 Pt 1):47-60. PubMed ID: 20880044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is a diabetes pay-for-performance program cost-effective under the National Health Insurance in Taiwan?
    Tan EC; Pwu RF; Chen DR; Yang MC
    Qual Life Res; 2014 Mar; 23(2):687-96. PubMed ID: 23975377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A diabetes pay-for-performance program and the competing causes of death among cancer survivors with type 2 diabetes in Taiwan.
    Hsieh HM; Chiu HC; Lin YT; Shin SJ
    Int J Qual Health Care; 2017 Aug; 29(4):512-520. PubMed ID: 28531317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.